Situational syncope: Response to head-up tilt testing and follow-up: Comparison with vasovagal syncope

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 7, 2004, Pages 918-923

  Livanis, Efthimios G ^a   Leftheriotis, Dionyssios ^a   Theodorakis, George N ^a   Flevari, Panagiota ^a   Zarvalis, Elias ^a   Kolokathis, Fotis ^a   Kremastinos, Dimitrios Th ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Follow up; Situational syncope; Tilt test

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUOXETINE; PROPRANOLOL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HEAD TILTING; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SYNCOPE; TREATMENT OUTCOME;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; SYNCOPE; SYNCOPE, VASOVAGAL; TILT-TABLE TEST;

EID: 3242804430     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00559.x     Document Type: Article

References (25)

1. Kosinksi DJ. Miscellaneous Causes of Syncope. In BP Grubb, B Olshansky (eds.): Syncope: Mechanisms and Management. Armonk, NY, Futura Publishing Co., 1998, pp. 297-303.
2. Task Force on Syncope, European Society of Cardiology: Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001; 22:1256-1306.
3. Brignole M, Menozzi C, Gianfranchi L, et al. Carotid sinus massage, eyeball compression, and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects. Am Heart J 1991; 122:1644-1651.
4. Theodorakis GN, Markianos M, Zarvalis E, et al. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome. J Am Coll Cardiol 2000; 36:174-178.
5. Benditt DG, Lurie KG, Adler SW, et al. Rationale and Methodology of Head-up Tilt Table Testing for Evaluation of Neurally Mediated (Cardioneurogenic) Syncope. In: PD Zipes, J Jalife. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pennsylvania, W.B. Saunders Co., 1995, pp. 1115-1129.
6. Flevari P, Livanis EG, Theodorakis GN, et al. Vasovagal syncope: A prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patient's well-being. J Am Coll Cardiol 2002; 40:499-504.
7. Sumiyoshi M, Nakata Y, Mineda Y, et al. Response to head-up tilt testing in patients with situational syncope. Am J Cardiol 1998; 82:1117-1118.
8. Mathias CJ, Kazushi D, Schatz I. Observations on recurrent syncope and presyncope in 641 patients. Lancet 2001; 357:348-353.
9. Benditt DG. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation. Pace 1997; 20:572-584.
10. Kapoor WN, Peterson J, Karpf M. Defecation syncope. A symptom with multiple etiologies. Arch Intern Med 1996; 146:2377-2379.
11. Kadish AH, Wechsler L, Marchlinski FE. Swallowing syncope: Observations in the absence of conduction system or esophageal disease. Am J Med 1986; 81:1098-1100.
12. Kakuchi H, Sato N, Kawamura Y. Swallow syncope associated with complete atrioventricular block and vasovagal syncope. Heart 2000; 83:702-704.
13. Basker MR, Cooper DKC. Oesophageal syncope. Ann R Coll Surg Engl 2000; 82:249-253.
14. Lee D, Beldner S, Pollaro F, et al. Cough-induced heart block. PACE 1999; 22:1270-1271.
15. Cunningham ET, Ravich WJ, Jones B, et al. Vagal reflexes referred from the upper aerodigestive tract: An infrequently recognized cause of common cardiorespiratory responses. Ann Intern Med 1992; 116:575-582.
16. Theodorakis GN, Markianos M, Livanis EG, et al. Central serotonergic responsiveness in neurocardiogenic syncope: A clomipramine test challenge. Circulation 1998; 98:2724-2730.
17. Saxena PR, Villalon CM. Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Pharmacol 1990; 15(Suppl 7):S17-S34.
18. Jones LF, Tackett RL. Interaction of propranolol with central serotonergic neurons. Life Sci 1998; 43:2249-2255.
19. Sheldon R, Rose S, Flanagan P, et al. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996; 93:973-981.
20. Sutton R. Vasovagal syncope: Prevalence and presentation. An algorhythm of management in the aviation environment. Eur Heart J 1999; 1(Suppl D):D109-D113.
21. Fenton AM, Hammill SC, Rea RF, et al. Vasovagal syncope. Ann Intern Med 2000; 133:714-725.
22. Mosqueda-Garcia R, Furlan R, Tank J, et al. The elucive pathophysiology of Vasovagal syncope. Circulation 2000; 102:2898-2906.
23. Reybrouk T, Heidbuchel H, Van De Werf F, et al. Tilt training: A treatment for malignant and recurrent neurocardiogenic syncope. PACE 2000; 23:493-498.
24. Theodorakis GN, Markianos M, Livanis EG, et al. Hormonal responses during tilt-table test in neurally mediated syncope. Am J Cardiol 1997; 79:1692-1695.
25. Mercader MA, Varghese PJ, Potolicchio SJ, et al. New insights into the mechanism of neurally mediated syncope. Heart 2002; 88:217-221.